These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 26215462)

  • 1. Basal buffer systems for a newly glycosylated recombinant human interferon-β with biophysical stability and DoE approaches.
    Kim NA; Song K; Lim DG; Hada S; Shin YK; Shin S; Jeong SH
    Eur J Pharm Sci; 2015 Oct; 78():177-89. PubMed ID: 26215462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fundamental analysis of recombinant human epidermal growth factor in solution with biophysical methods.
    Kim NA; Lim DG; Lim JY; Kim KH; Jeong SH
    Drug Dev Ind Pharm; 2015 Feb; 41(2):300-6. PubMed ID: 24502269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of protein solution by a novel experimental design method using thermodynamic properties.
    Kim NA; An IB; Lee SY; Park ES; Jeong SH
    Arch Pharm Res; 2012 Sep; 35(9):1609-19. PubMed ID: 23054718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solution behavior of IFN-beta-1a: an empirical phase diagram based approach.
    Fan H; Ralston J; Dibiase M; Faulkner E; Middaugh CR
    J Pharm Sci; 2005 Sep; 94(9):1893-911. PubMed ID: 16052555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycoengineering of interferon-β 1a improves its biophysical and pharmacokinetic properties.
    Song K; Yoon IS; Kim NA; Kim DH; Lee J; Lee HJ; Lee S; Choi S; Choi MK; Kim HH; Jeong SH; Son WS; Kim DD; Shin YK
    PLoS One; 2014; 9(5):e96967. PubMed ID: 24858932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of pH and buffer concentration on the thermal stability of etanercept using DSC and DLS.
    Kim NA; An IB; Lim DG; Lim JY; Lee SY; Shim WS; Kang NG; Jeong SH
    Biol Pharm Bull; 2014; 37(5):808-16. PubMed ID: 24790003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biophysical stability of hyFc fusion protein with regards to buffers and various excipients.
    Lim JY; Kim NA; Lim DG; Eun CY; Choi D; Jeong SH
    Int J Biol Macromol; 2016 May; 86():622-9. PubMed ID: 26851357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved Stability of a Model IgG3 by DoE-Based Evaluation of Buffer Formulations.
    Chavez BK; Agarabi CD; Read EK; Boyne MT; Khan MA; Brorson KA
    Biomed Res Int; 2016; 2016():2074149. PubMed ID: 27042659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive evaluation of etanercept stability in various concentrations with biophysical assessment.
    Kim NA; Lim DG; Lim JY; Kim KH; Jeong SH
    Int J Pharm; 2014 Jan; 460(1-2):108-18. PubMed ID: 24269208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigating the Degradation Behaviors of a Therapeutic Monoclonal Antibody Associated with pH and Buffer Species.
    Zheng S; Qiu D; Adams M; Li J; Mantri RV; Gandhi R
    AAPS PharmSciTech; 2017 Jan; 18(1):42-48. PubMed ID: 26340951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biophysical evaluation of hybrid Fc fusion protein of hGH to achieve basal buffer system.
    Kim NA; An IB; Lim HS; Yang SI; Jeong SH
    Int J Pharm; 2016 Nov; 513(1-2):421-430. PubMed ID: 27659863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preformulation development of recombinant pegylated staphylokinase SY161 using statistical design.
    Bedu-Addo F; Moreadith R; Advant SJ
    AAPS PharmSci; 2002; 4(4):E19. PubMed ID: 12645991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermofluor-based optimization strategy for the stabilization and crystallization of Campylobacter jejuni desulforubrerythrin.
    Santos SP; Bandeiras TM; Pinto AF; Teixeira M; Carrondo MA; Romão CV
    Protein Expr Purif; 2012 Feb; 81(2):193-200. PubMed ID: 22051151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetate- and Citrate-Specific Ion Effects on Unfolding and Temperature-Dependent Aggregation Rates of Anti-Streptavidin IgG1.
    Barnett GV; Razinkov VI; Kerwin BA; Hillsley A; Roberts CJ
    J Pharm Sci; 2016 Mar; 105(3):1066-73. PubMed ID: 26886346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of recombinant human interferon beta interacting with particles of glass, metal, and polystyrene.
    Van Beers MM; Gilli F; Schellekens H; Randolph TW; Jiskoot W
    J Pharm Sci; 2012 Jan; 101(1):187-99. PubMed ID: 21918983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nano Differential Scanning Fluorimetry-Based Thermal Stability Screening and Optimal Buffer Selection for Immunoglobulin G.
    Kim SH; Yoo HJ; Park EJ; Na DH
    Pharmaceuticals (Basel); 2021 Dec; 15(1):. PubMed ID: 35056086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The stability of bFGF against thermal denaturation.
    Vemuri S; Beylin I; Sluzky V; Stratton P; Eberlein G; Wang YJ
    J Pharm Pharmacol; 1994 Jun; 46(6):481-6. PubMed ID: 7932043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization of Zwitterion-based solutions to dissect the relative effects of solution pH and ionic strength on the aggregation behavior and conformational stability of a fusion protein.
    Zhou R; Nashine V; Palm T; Gandhi R; Adams M
    J Pharm Sci; 2014 Oct; 103(10):3065-74. PubMed ID: 25139470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thermal denaturation of human gamma-interferon. A calorimetric and spectroscopic study.
    Beldarrain A; López-Lacomba JL; Furrazola G; Barberia D; Cortijo M
    Biochemistry; 1999 Jun; 38(24):7865-73. PubMed ID: 10387027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for stability and compatibility conditions of recombinant human epidermal growth factor for parenteral formulation: effect of pH, buffers, and excipients.
    Santana H; González Y; Campana PT; Noda J; Amarantes O; Itri R; Beldarraín A; Páez R
    Int J Pharm; 2013 Aug; 452(1-2):52-62. PubMed ID: 23624083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.